The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation

Cancer Research

Volumn 70, Issue 2, 2010, Pages 719-729

  Kemper, Kristel ^a   Sprick, Martin R ^a   De Bree, Martijn ^a   Scopelliti, Alessandro ^b   Vermeulen, Louis ^a   Hoek, Maarten ^c   Zeilstra, Jurrit ^a   Pals, Steven T ^a   Mehmet, Huseyin ^c   Stassi, Giorgio ^b   Medema, Jan Paul ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Cellular and Molecular Pathophysiology Laboratory   (Italy)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; EPITOPE; MESSENGER RNA;

ARTICLE; BIOTINYLATION; CANCER STEM CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL MEMBRANE; CELL SURFACE; CLINICAL ARTICLE; CLONOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTANT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TERTIARY STRUCTURE; RNA SPLICING; TUMOR CELL;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; COLONIC NEOPLASMS; DOWN-REGULATION; EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; PEPTIDES; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 76549120193     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1820     Document Type: Article

References (47)

1. Borovski T, Vermeulen L, Sprick MR, Medema JP. One renegade cancer stem cell? Cell Cycle 2009;8:803-8.
2. Vermeulen L, Sprick MR, Kemper K, Stassi G, Medema JP. Cancer stem cells-old concepts, new insights. Cell Death Differ 2008;15: 947-58.
3. Vassilopoulos A, Wang RH, Petrovas C, Ambrozak D, Koup R, Deng CX. Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells. Int J Biol Sci 2008;4:133-42.
4. Vermeulen L, Todaro M, de Sousa MF, Sprick MR, Kemper K, Perez AM, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008;105:13427-32.
5. Al Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
6. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65: 5506-11.
7. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973-8.
8. Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007;43:935-46.
9. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10.
10. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-5.
11. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Neurosurgery 2003;53:487-8.
12. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1:389-402.
13. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009;69:1302-13.
14. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67.
15. Addla SK, Brown MD, Hart CA, Ramani VAC, Clarke NW. Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells. Am J Physiol Renal Physiol 2008; 295:F680-7.
16. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004;101:14228-33.
17. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007;67:4827-33.
18. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-21.
19. Yin A, Miraglia S, Magee K, Zanjani E, Ogawa M, Buck DW. AC133, a novel monoclonal antibody to human hematopoietic stem and progenitor cells. Exp Hematol 1997;25:523.
20. + cancer stem cells. Neuro-Oncology 2004;6:348.
21. Ma S, Chan KW, Hu L, Lee TKW, Wo JYH, Ng IL, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-56.
22. + stem cells in a cell line of human osteosarcoma (SAOS2). Cytometry Part A 2008;73A:108.
23. Green CL, Loken M, Buck D, Deeg HJ. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML). Leukemia 2000; 14:770-2.
24. Snippert H, van Es J, van den Born M, Begthel H, Stange D, Barker N, et al. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 2009;136:2187-94.
25. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009;457:603-7.
26. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A. Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. Bmc Cancer 2008;8:48.
27. Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H, et al. The stem cell marker CD133 (prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 2008;56:977-93.
28. - metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-20.
29. Mullauer FB, Kessler JH, Medema JP. Betulin is a potent anti-tumor agent that is enhanced by cholesterol. Plos One 2009;4.
30. Yu Y, Flint A, Dvorin EL, Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 2002;277:20711-6.
31. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 2004;103:2055-61.
32. Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB, Corbeil D. Identification of novel prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci 2004;117:4301-11.
33. Fargeas CA, Huttner WB, Corbeil D. Nomenclature of prominin-1 (CD133) splice variants-an update. Tissue Antigens 2007;69:602-6.
34. Xin D, Hu L, Kong X. Alternative promoters influence alternative splicing at the genomic level. Plos One 2008;3:e2377.
35. Lardon J, Corbeil D, Huttner WB, Ling ZD, Bouwens L. Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 2008;36:E1-6.
36. Corbeil D, Roper K, Weigmann A, Huttner WB. AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood 1998;91:2625-6.
37. Bidlingmaier S, Zhu XD, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008;86:1025-32.
38. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. Journal of Pathology 2008;214:3-9.
39. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, Watt SM, et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-20.
40. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000;2:582-92.
41. Lee J, Kotliarova S, Kotliarov Y, Li AG, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403.
42. Hutchins JT, Reading CL. Characterization of mono-O-acetylated, di-O-acetylated, and tri-O-acetylated sialic acids on human cells. J Cell Biochem 1988;37:37-48.
43. Hutchins JT, Reading CL, Giavazzi R, Hoaglund J, Jessup JM. Distribution of mono-O-acetylated, di-O-acetylated, and tri-O-acetylated sialic acids in normal and neoplastic colon. Cancer Res 1988; 48:483-9.
44. Taïeb N, Maresca M, Guo XJ, Garmy N, Fantini J, Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 2009; 278:164-73.
45. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005;319:15-26.
46. Yi JM, Tsai HC, Glockner SC, Lin S, Ohm JE, Easwaran H, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008;68:8094-103.
47. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, et al. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for metastasis of human colon cancer. J Pathol 2009;219:427-34.